Next-generation antimicrobial susceptibility testing.

Area of Science:

• Clinical microbiology
• Infectious disease management
• Antimicrobial stewardship

Background:

• Antimicrobial resistance (AMR) is a critical global health challenge.
• The clinical microbiology laboratory is essential for guiding antimicrobial therapy.
• Current antimicrobial susceptibility testing (AST) methods face limitations.

Purpose of the Study:

• To explore emerging innovative methods for antimicrobial susceptibility testing (AST).
• To assess the potential clinical utility of novel AST approaches.
• To identify alternatives to current standard AST methodologies.

Main Methods:

• Review of recent scientific literature on novel AST technologies.
• Analysis of the potential advantages and limitations of new methods.
• Discussion of the clinical applicability and future prospects of innovative AST.

Main Results:

• Several innovative AST methods show promise for rapid and accurate results.
• These novel techniques could potentially improve patient outcomes and combat AMR.
• The transition to new AST methods requires further validation and integration.

Conclusions:

• Innovative AST methods offer a promising future for clinical microbiology.
• These advancements are crucial for optimizing treatment of infections and addressing AMR.
• The clinical microbiology laboratory will continue to play a pivotal role in infection management.